Digitalization, Sustainability, and Process Analytical Technology - Trends in Pharmaceutical and Bio-Pharmaceutical Industry 

September 21, 2022
8:00 a.m. PDT, 11:00 a.m. EDT, 16:00 BST, 17:00 CEST - Duration: 60 Minutes


Often broken into economic, environmental, and social concepts, sustainability can be defined as the ability to maintain or support a process over time. Other definitions include the capacity of fulfilling the needs of current generation without compromising the needs of future generations, while ensuring a balance between economic growth, environmental care and social well-being. But what does this really mean for your organization and how can it be practically implemented? As an example, does digitalization aid sustainability or does it have an environmental impact by itself?

Join this webinar with Mark Henson, Head of Sustainable CMC at Takeda, Mark Milton, Associate Fellow at Takeda, Andrew Phillips, Head of digitalization, Pharmaceutical Sciences, at Astra Zeneca, Martin Gadsby, co-founder of Optimal Industrial Technologies and PAT expert and moderated by Anna Codina, Director of the Pharmaceutical Business Unit at Bruker BioSpin. They will discuss the correlation between digitalization, sustainability and process analytical technology and present practical examples of their implementation in pharma and biopharma.

Helium production and supply sustainability will also be discussed in the context of nuclear magnetic resonance (NMR) and solutions presented for helium recycling, as well as the latest results obtained from a cryogen-free benchtop spectrometer used as a smart detector for flow chemistry. Continuous-flow chemistry, compact and highly efficient by design, offers great advantages when combined with green chemistry principles and process analytical technology toward the development of a more sustainable chemistry and bioproduction.

Key Learning Objectives:
  • Key challenges in digital transformation
  • Gain insights on sustainability chemistry goals the pharmaceutical industry
  • Modern technologies that enable greener chemistry
  • Sustainability through the next generation of drugs
  • Economic significance and current challenges in the pharmaceutical industry
  • Digitalization and its impact from drug discovery to development
  • Insights into machine learning and artificial intelligence applications to Process Analytical Technology (PAT)
Who Should Attend:
  • Pharmaceutical & Fine Chemists
  • Academic Chemistry Researchers
  • Process & Development Chemists
  • Drug Discovery and Development
  • Manufacturing in Pharmaceutical industry
  • Sustainability Directors

Brought to you by:
Bruker Biospin


Mark Henson
Head of Sustainable CMC,
Andy Phillips
Head of Digitization, Pharmaceutical Sciences,
Astra Zeneca
Martin Gadsby
Owner and Director,
Optimal Industrial Automation
Anna Codina
Director Pharmaceutical Business Unit,
Bruker Biospin
Mark Milton
Associate Fellow,
Kelly McSweeney
Contributing Editor,
C&EN Media Group


*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

© 2023 American Chemical Society, 1155 16th St NW, Washington, DC 20036, USA. View our Privacy Policy